Kecia Ford
Internal Medicine · East Meadow, NYNPI 1063741023
Payments from drug & device makers
Across 199 payments — averaging $38.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BETA Bionics, Inc.$1K
- Amgen$1K
- Biohaven Pharmaceutical Holding Company Ltd.$791
- Dexcom, Inc.$783
- AbbVie$735
- AstraZeneca$631
- plus $3K from 22 others
What the payments were for
- Food & beverage$7,39597%
- Education$931%
- Gifts$1192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BETA Bionics, Inc. | 11 | $1,021 |
| Amgen | 26 | $1,017 |
| Biohaven Pharmaceutical Holding Company Ltd. | 21 | $791 |
| Dexcom, Inc. | 11 | $783 |
| AbbVie | 20 | $735 |
| AstraZeneca | 12 | $631 |
| Novo Nordisk | 26 | $539 |
| Global Blood Therapeutics, Inc. | 6 | $229 |
| Mannkind Corporation | 5 | $193 |
| Bayer | 5 | $191 |
| Exact Sciences | 9 | $189 |
| Kowa Pharmaceuticals America, Inc. | 6 | $186 |
| GSK | 8 | $178 |
| Abbott | 2 | $146 |
| Pfizer | 7 | $145 |
| Eisai Inc. | 1 | $125 |
| Lilly USA, LLC | 5 | $113 |
| Shield Therapeutics Inc | 4 | $78 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $57 |
| Merck | 2 | $44 |
| Optinose US, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Sanofi Pasteur Inc. | 1 | $28 |
| Dynavax Technologies Corporation | 1 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Renalytix AI, Inc. | 1 | $24 |
| Acarix USA Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$2,725
- iLet Insulin Infusion Kit Inset$694
- iLet Insulin Infusion Kit Contact Detach$694
- Repatha$498
- DEXCOM G6 TRANSMITTER$436
- NURTEC ODT$414
- BREZTRI$374
- UBRELVY$246
- TEPEZZA$125
- Leqembi$125
- QULIPTA$125
- RYBELSUS$122
- ZORYVE$122
- AIRSUPRA$120
- FREESTYLE LIBRE 3$119
- DEXCOM G7 GSS (161)$106
How this compares
$7,607 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LofenaDiclofenac Potassium | 36 | $212,464 |
| JardianceEmpagliflozin | 136 | $156,604 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 48 | $120,938 |
| JanuviaSitagliptin Phosphate | 96 | $117,523 |
| KerendiaFinerenone | 64 | $86,281 |
| AfrezzaInsulin Regular, Human | 34 | $61,577 |
| RybelsusSemaglutide | 45 | $50,078 |
| Diclofenac Potassium | 26 | $48,412 |
| OzempicSemaglutide | 40 | $40,220 |
| LinzessLinaclotide | 44 | $36,129 |
| Diclofenac Sodium | 89 | $27,641 |
| JanumetSitagliptin Phos/Metformin Hcl | 27 | $27,010 |
| TradjentaLinagliptin | 25 | $26,984 |
| Nurtec OdtRimegepant Sulfate | 14 | $26,877 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $19,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet | $44 | $144,533123 claims |
| Novo NordiskRybelsus, Ozempic | $539 | $90,29885 claims |
| BayerKerendia | $191 | $86,28164 claims |
| Mannkind CorporationAfrezza | $193 | $61,57734 claims |
| PfizerNurtec Odt, Eliquis | $145 | $42,15830 claims |
| AbbVieLinzess | $735 | $36,12944 claims |
| GSKTrelegy Ellipta, Shingrix | $178 | $22,38141 claims |
| AstraZenecaBrilinta | $631 | $11,28422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in East Meadow
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.